Biocryst Pharmaceuticals reported $604.46M in Loan Capital for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Daiichi Sankyo 4568:JP JPY 101.79B 94M
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Glaxosmithkline GSK:US GBP 17.04B 2.29B
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Ptc Therapeutics PTCT:US USD 981.61M 165K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 22.37B 6.29B
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K